News

Biosenta Inc. announced that Gary LeRoux, past President and CEO of the Canadian Coatings Association (CCA), has joined the company’s advisory board. Mr. LeRoux brings more than 30 years of leadership experience. “Gary’s unmatched experience in coatings, regulatory policy, and industry partnerships is a tremendous asset as we advance the commercialization of Tri-­Filler®,” said Am Gill, President and CEO of Biosenta. “His perspective will help us accelerate adoption across ke

Discover how veteran finance executive Tim Gillespie, CFA, joins Biosenta as a strategic advisor to enhance their antimicrobial technology strategy.

Validated University of Calgary research demonstrates broad-spectrum efficacy of core-shell calcium hydroxide-calcium carbonate (CSCC(TM)) particles. Biosenta Inc. announced that two independent, peer-reviewed studies confirmed that its proprietary Tri-Filler™ nanoparticles achieved complete (100%) bactericidal activity against multiple World Health Organization (WHO) priority pathogens and keep working far longer than conventional biocides.

Validated University of Calgary research demonstrates broad-spectrum efficacy of core-shell calcium hydroxide-calcium carbonate (CSCC(TM)) particles. Biosenta Inc. announced that two independent, peer-reviewed studies confirmed that its proprietary Tri-Filler™ nanoparticles achieved complete (100%) bactericidal activity against multiple World Health Organization (WHO) priority pathogens and keep working far longer than conventional biocides.